Fat mass- and obesity-associated protein (FTO) was recently reported to participate in multiple tumorigenic processes including immune evasion in several malignant tumors (Li et al., 2017; Zhao et al., 2020; Tao et al., 2021; Zhou et al., 2021), implying the therapeutic potential of FTO inhibition in treating multiple cancers. This evidence concerns the gene FTO and cancer.